FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology and pediatrics. The age of the patient, the volume of the left and right atria as a percentage of the predicted individual normal calue, left ventricular ejection fraction detected by echocardiography, as well as daily average and maximum heart rate according to daily ECG monitoring are determined. Based on these factors, the probability of efficient antiarrhythmic therapy (AAT) for children is estimated by means of a discriminant equation. Upon a receipt of <-0.488, a high probability of AAT efficiency for children is predicted.
EFFECT: invention allows maximum personalization and definition of children treatment tactic, reduction of pill burden on the child's body and timely application of other treatment methods in case of predicted prolonged AAT ineffeciency; does not involve invasive diagnostic measures, which is especially important for infants and preschool children.
4 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTION OF RECURRENT ATRIAL FIBRILLATION FOLLOWING CARDIOSURGICAL OPERATIONS | 2014 |
|
RU2567920C1 |
METHOD OF DIAGNOSING ATRIOVENTRICULAR NODAL ECTOPIC TACHICARDIA IN CHILDREN AFTER SURGICAL TREATMENT OF VALVULAR DEFECTS BY DETECTION OF ATRIOVENTRICULAR DISSOCIATION ON ECG WITH APPLICATION OF MEDICATIONS (ITS VERSIONS) | 2010 |
|
RU2453264C2 |
METHOD FOR PREDICTION OF UNFAVOURABLE OUTCOME OF HYPERTROPHIC CARDIOMYOPATHY | 2013 |
|
RU2527768C1 |
METHOD OF EFFECTIVE DOSE SELECTION OF BETA-ADRENERGIC BLOCKING AGENTS IN CARDIOMYOPATHIES IN CHILDREN | 2019 |
|
RU2719909C1 |
METHOD FOR CORRECTION OF ARRHYTHMIA IN OLDER CHILDREN SUFFERING RESPIRATORY TUBERCULOSIS WITH MULTIPLE AND EXTENSIVE DRUG RESISTANCE MTB RECEIVING BEDAQUILINE IN CHEMOTHERAPY MODES | 2023 |
|
RU2826083C1 |
METHOD FOR PREVENTION OF CARDIAC RHYTHM DISTURBANCE IN CORONARY BYPASS | 2009 |
|
RU2392939C1 |
METHOD FOR TREATING ATRIAL FIBRILLATION IN CASE OF MYOCARDIAL INFARCTION | 2005 |
|
RU2268713C1 |
METHOD OF PREDICTING THE EFFECTIVENESS OF THE PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY AS PRIMARY PREVENTION OF ATRIAL FIBRILLATION IN THE PATIENTS WITH ATRIAL EXTRASYSTOLE | 2018 |
|
RU2688394C1 |
METHOD FOR TREATING PERSISTING FORM OF ATRIAL FIBRILLATION | 2006 |
|
RU2320328C2 |
METHOD FOR PREDICTION OF ANTIARRHYTHMIC EFFECTIVENESS OF BETA-BLOCKERS IN PREGNANT WOMEN WITH HIGH-GRADE VENTRICULAR ARRHYTHMIAS WITHOUT STRUCTURAL PATHOLOGY OF HEART | 2019 |
|
RU2728591C1 |
Authors
Dates
2017-03-01—Published
2015-12-08—Filed